Axcel Fusidic Acid-B Cream

Axcel Fusidic Acid-B Cream is a combination topical preparation containing fusidic acid, an antibiotic, together with betamethasone, a corticosteroid. This dual-action formula is used to treat skin infections that are complicated by significant inflammation, such as infected eczema or infected dermatitis, where both the bacterial infection and the accompanying redness, itching, and swelling need to be addressed together.

Because it contains a corticosteroid combined with an antibiotic, Axcel Fusidic Acid-B Cream is only available in Malaysia through DoctorOnCall with a valid prescription. An online consultation with a DoctorOnCall doctor is required so the doctor can confirm that the skin condition is suitable for combined antibiotic-steroid treatment and prescribe an appropriate duration of use before the cream is dispensed.

Fusidic acid works by inhibiting bacterial protein synthesis, stopping susceptible bacteria such as Staphylococcus aureus from multiplying and allowing the infection to clear. Betamethasone, the corticosteroid component, binds to glucocorticoid receptors in skin cells to suppress the release of inflammatory mediators, reducing redness, swelling, and itching. Together, the two ingredients treat both the underlying infection and the inflammatory skin response at the same time.

Axcel Fusidic Acid-B Cream should only be used as directed by the prescribing doctor. A thin layer is typically applied to the affected area two to three times a day, or as instructed, and gently rubbed in. Hands should be washed before and after application unless the hands are the area being treated, and the cream should not be applied more widely or for longer than prescribed.

The dosage and duration of Axcel Fusidic Acid-B Cream must be determined by the prescribing doctor, taking into account the location, extent, and severity of the infected skin condition. Treatment courses are usually limited to a short period, commonly around one to two weeks, because prolonged use of the corticosteroid component increases the risk of skin thinning and other steroid-related side effects, and prolonged antibiotic use increases the risk of bacterial resistance.

Axcel Fusidic Acid-B Cream should be used within the shelf-life period printed on the packaging when stored under the recommended conditions. Do not use the product beyond its expiry date, and dispose of any unused or expired cream responsibly.

Store Axcel Fusidic Acid-B Cream below 30°C in a cool, dry place away from direct sunlight and moisture. Keep the tube tightly closed after use and out of the reach of children.

• Known hypersensitivity to fusidic acid, betamethasone, or any other ingredient in the cream
• Untreated viral skin infections (such as cold sores, chickenpox, or shingles) or untreated fungal infections at the application site
• Rosacea or acne vulgaris on the face
• Perioral dermatitis
• Not for use in or near the eyes
• Not recommended for prolonged, continuous use without medical review

• Concurrent use with other topical corticosteroid or antibiotic products should be avoided unless directed by a doctor
• Using occlusive dressings over the treated area without medical advice can increase absorption of both active ingredients and the risk of side effects
• Inform your doctor of all other topical or systemic medications you are using before starting treatment

• Apply only a thin layer to the infected, inflamed area as prescribed
• Complete the prescribed course even if the skin appears to improve, to reduce the risk of the infection returning or antibiotic resistance developing
• Do not use for longer than the doctor has advised
• Avoid covering the treated area with airtight dressings unless instructed
• Return for a doctor’s follow-up if the skin condition does not improve or worsens

Axcel Fusidic Acid-B Cream combines an antibiotic and a corticosteroid, so its use should be monitored by a doctor, particularly regarding treatment duration, to reduce the risk of both antibiotic resistance and steroid-related skin changes. Patients should attend follow-up consultations with their DoctorOnCall doctor as advised to assess how the infection and inflammation are responding to treatment.